title: Adjuvant Chemotherapy for Bladder Cancer: Using Population-Based Data to Fill a Void of Prospective Evidence.
authors.affiliation: City of Hope Comprehensive Cancer Center, Duarte, CA spal@coh.org.
authors.forename: Sumanta K
authors.initials: SK
authors.lastname: Pal
authors.affiliation: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Agarwal
authors.affiliation: Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Petros
authors.initials: P
authors.lastname: Grivas
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Toni
authors.initials: T
authors.lastname: Choueiri
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000627:therapeutic use; D015653:Cystectomy; D006801:Humans; D020360:Neoadjuvant Therapy; D011446:Prospective Studies; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D002945:Cisplatin